Academician
EYÜP NACİ TİFTİK
PROFESÖR
MERSİN ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Hematoloji (İç Hastalıkları)
A quick look at recorded outputs — details below.
- Articles 80
- Projects 0
- Books 7
- Proceedings 31
- Patents 0
- Artistic 0
Scopus (SJR)
Q1
4
Q2
15
Q3
18
Q4
12
WoS (JCR)
Q1
4
Q2
4
Q3
10
Q4
34
TR Index
21
articles
Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.
Top 1% articles
2
Top 10% articles
8
Avg percentile
61.0%
Top 1% share
3.3%
Top 10% share
13.1%
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Article list
- 2025 Novel vanillin-derived Schiff Bases: Synthesis, characterization, antibacterial activity, enzyme inhibition, antioxidant activity, anti-inflammatory activity on LPS-induced RAW264.7 macrophage cell line, and In Silico studies YÖKSİS SJR Q2 JCR Q2 OpenAlex top 1% OpenAlex 99.1%
- 2025 Salicylaldehyde-derived Hydrazones: Synthesis, characterization, antibacterial activity, antioxidant and anti-inflammatory effects on LPS-induced RAW264.7 macrophage cells, drug-likeness properties, and molecular docking analysis YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 95.1%
- 2025 Hepatitis E Virus (HEV) Seroprevalence in Cryptogenic Cirrhosis: From Evidence of High Frequency to the Impact on Disease Progression YÖKSİS SJR Q2 JCR Q1 OpenAlex 71.8%
- 2022 Yeni tanı kronik myeloid lösemili hastalarda tiyol/disülfit dengesi ve Sokal prognostik skoru ile ilişkisi YÖKSİS TR Index OpenAlex 3.8%
- 2022 Can galectin-3 be used to predict the severity of vasoocclusive crisis in patients with sickle cell anaemia? YÖKSİS OpenAlex 52.6%
- 2021 Use of gemtuzumab ozogamicin in relapsed refractory acute myeloid leukemia: Multi-center real life data from Turkey YÖKSİS SJR Q4 JCR Q4 OpenAlex 65.0%
- 2021 Plasmapheresis Experience of Pediatric Intensive Care in 5 Years YÖKSİS TR Index OpenAlex 42.1%
- 2021 Are Platelet-related Parameters Predictive of the Prognosis of Hodgkin's Lymphoma? YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 51.8%
- 2020 Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia YÖKSİS SJR Q3 JCR Q4 OpenAlex 8.3%
- 2020 Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia YÖKSİS SJR Q3 JCR Q4 OpenAlex 8.5%
- 2020 Seroprevalence of Asymptomatic Leishmania spp. Carriage Among Blood Donors in Leishmaniasis Endemic Area in Turkey YÖKSİS TR Index JCR Q4 OpenAlex 4.4%
- 2020 Safety and efficacy of non‐steroidal anti‐inflammatory drugs to reduce ileus after colorectal surgery YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 98.3%
- 2020 Safety of hospital discharge before return of bowel function after elective colorectal surgery YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 92.3%
- 2019 A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 78.2%
- 2017 Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases YÖKSİS SJR Q4 JCR Q4 OpenAlex 79.3%
- 2016 The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 67.1%
- 2016 AZACITIDINE VERSUS DECITABINE IN PATIENTS WITH REFRACTORY ANEMIA WITH EXCESS BLAST-RESULTS OF MULTICENTER STUDY YÖKSİS SJR Q2 JCR Q3 OpenAlex 83.3%
- 2015 MicroRNA Expression Analysis in Patients with Primary Myelofibrosis, Polycythemia vera and Essential Thrombocythemia YÖKSİS SJR Q4 JCR Q4 OpenAlex 72.6%
- 2015 Post-Authorization Safety of Lenalidomide + Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma in Turkey YÖKSİS SJR Q2 JCR Q3 OpenAlex 66.3%
- 2015 Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma YÖKSİS SJR Q2 JCR Q4 OpenAlex 89.0%